01 3Bristol-Myers Squibb Pharmaceutical Group (Div. Of Bristol-Myers Squibb Can. Inc.)
02 5Gilead Sciences Canada Inc.
03 6Blank
01 31181075
02 31205076
03 41338670
04 11340253
05 12433280
06 12530774
07 12708703
01 8Aztreonam
02 6Blank
01 5 POWDER FOR SOLUTION
02 3Powder
03 6Blank
01 32002-06-06
02 32003-05-27
03 42013-10-22
04 12015-12-15
05 22021-12-20
06 12024-07-01
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Brand Name : AZACTAM
Patent Number : 1338670
Filing Date :
Strength per Unit : 2 gr/ vial
Dosage Form : Powder
Human Or VET : Human
Route of Administration : parenteral
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Brand Name : AZACTAM
Patent Number : 1338670
Filing Date :
Strength per Unit : 1 gr
Dosage Form : Powder
Human Or VET : Human
Route of Administration : parenteral
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Brand Name : AZACTAM
Patent Number : 1338670
Filing Date :
Strength per Unit : 500 mg/vial
Dosage Form : Powder
Human Or VET : Human
Route of Administration : parenteral
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Patent Expiration Date : 2015-12-15
Date Granted : 1998-12-15
Brand Name : CAYSTON
Patent Number : 1340253
Filing Date : 1981-02-06
Strength per Unit : 75 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2015-12-15
Date Granted : 1998-12-15
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Brand Name : CAYSTON
Patent Number : 1338670
Filing Date : 1981-02-06
Strength per Unit : 75 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Patent Expiration Date : 2021-12-20
Date Granted : 2012-12-04
Brand Name : CAYSTON
Patent Number : 2708703
Filing Date : 2001-12-20
Strength per Unit : 75 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2021-12-20
Date Granted : 2012-12-04
Patent Expiration Date : 2024-07-01
Date Granted : 2011-10-18
Brand Name : CAYSTON
Patent Number : 2530774
Filing Date : 2004-07-01
Strength per Unit : 75 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2024-07-01
Date Granted : 2011-10-18
Patent Expiration Date : 2021-12-20
Date Granted : 2010-09-21
Brand Name : CAYSTON
Patent Number : 2433280
Filing Date : 2001-12-20
Strength per Unit : 75 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2021-12-20
Date Granted : 2010-09-21
Patent Expiration Date : 2002-06-06
Date Granted :
Brand Name :
Patent Number : 1181075
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2002-06-06
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2002-06-06
Date Granted :
Brand Name :
Patent Number : 1181075
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2002-06-06
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
